(1)
The Role of COPD in Survival of NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Meta-Analysis. Biomol Biomed 2025, 25 (11), 2428–2438. https://doi.org/10.17305/bb.2025.12355.